NorthStar Medical Radioisotopes, LLC is an early stage company destined to take advantage of the challenging, ever changing and dynamic nuclear medicine market. NorthStar Medical Radioisotopes is strategically equipped to become a key player in this market with products and services for diagnostic and therapeutic radioisotopes.  Today, the industry is supplied from non-US based producers using primarily highly enriched uranium.  Using its novel separation system, NorthStar believes it will become the first US supplier of important medical radioisotopes using non-uranium based materials.

Rapid market expansion is occurring in diagnostic radioisotope enhanced imaging procedures (CatScan, MRI, X-Ray and ultrasound) and more importantly radioisotopes are being employed as a therapy for cancer, leukemia, heart disease, Parkinson’s Disease and other diseases. There is a fundamental belief that herein lies the cure for deadly and debilitating diseases being treated with molecules which can seek and attach radioisotopes to tumors and cancerous growths.